Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Nogapendekin alfa inbakicept
BIOLOGICAL
2 trials
Sponsors
Seth Pollack
, Washington University School of Medicine
Conditions
Myxoid Liposarcoma
Non-small Cell Lung Cancer Recurrent
Non-small Cell Lung Cancer Stage IV
Round Cell Liposarcoma
Synovial Sarcoma
Early Phase 1
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Recruiting
NCT07261657
Seth Pollack
Myxoid Liposarcoma, Round Cell Liposarcoma, Synovial Sarcoma
Start: 2026-04-13
End: 2032-09-02
Target: 8
Updated: 2026-08-27
Phase 1
First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Recruiting
NCT07355205
Washington University School of Medicine
Non-small Cell Lung Cancer Recurrent, Non-small Cell Lung Cancer Stage IV
Start: 2026-07-07
End: 2032-07-31
Target: 26
Updated: 2026-07-10